Trial Profile
A Randomized, Double Blind, Trial of Metformin and Atorvastatin in Delaying Androgen Deprivation Therapy Among Men With Rising PSA Following Radical Prostatectomy or Radiotherapy: The LIGAND (LIpitor and biGuanide to Androgen Delay) Trial
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Metformin
- Indications Adenocarcinoma; Prostate cancer
- Focus Therapeutic Use
- Acronyms LIGAND
- 16 Apr 2021 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 10 Jan 2020 Planned initiation date changed from 1 Apr 2019 to 1 Jun 2019.
- 08 Apr 2019 Planned initiation date changed from 1 Jan 2019 to 1 Apr 2019.